NCT03570671

Brief Summary

With regard to the characteristics of spasm segment, had been clearly described by other invasive imaging methods including intravascular ultrasound and optical coherence tomography. However, there is potential risk during these invasive procedures, such as severe myocardial ischemia or fatal arrhythmia. Presently available imaging test for coronary artery disease in multi detector-row computed tomography angiography (MDCTA) evaluation has high diagnostic accuracy to evaluate coronary artery stenosis. However, previous report assessing imaging findings or diagnostic accuracy of MDCTA in patients with vasospastic angina (VSA) is lacking.

Trial Health

43
At Risk

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Trial has exceeded expected completion date
Enrollment
90

participants targeted

Target at P50-P75 for not_applicable

Timeline
Completed

Started Mar 2018

Longer than P75 for not_applicable

Geographic Reach
1 country

1 active site

Status
unknown

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

March 1, 2018

Completed
3 months until next milestone

First Submitted

Initial submission to the registry

May 29, 2018

Completed
29 days until next milestone

First Posted

Study publicly available on registry

June 27, 2018

Completed
2.9 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

May 31, 2021

Completed
1 month until next milestone

Study Completion

Last participant's last visit for all outcomes

July 1, 2021

Completed
Last Updated

August 4, 2020

Status Verified

August 1, 2020

Enrollment Period

3.3 years

First QC Date

May 29, 2018

Last Update Submit

August 3, 2020

Conditions

Keywords

MDCTACoronary artery spasm

Outcome Measures

Primary Outcomes (1)

  • Safety and Tolerability

    MDCTA procedure: all subjects will undergo MDCTA without a vasodilator ("initial CT") in the early morning before the ergonovine provocation spasm test. Subsequent "IV nitrate CT" will be allowed at a 3-day washout period after the first contrast usage. The scan protocol for the IV nitrate CT is as follows: during continuous injection of the intravenous vasodilating agent (isosorbidedinitrate 2 mg/hr), blood pressure will be checked every 2 minutes. When both the systolic and diastolic blood pressure decrease by 10 mmHg in comparison to the initial value, the CT scan initiate and images will be acquired during the nitrate infusion. Investigators define the positive criteria for VSA on MDCTA as follows: 1. Significant stenosis (≥ 50%) with negative remodeling but no definite evidence of plaques, which completely dilated on IV nitrate CT, or 2. Diffuse small diameter (\< 2mm) of a major coronary artery with beaded appearance which completely dilated on IV nitrate CT.

    3 days

Secondary Outcomes (5)

  • Coronary vessel distensibility

    3 days

  • Cutoff value of coronary vessel distensibility index

    3 days

  • Incidence of multi-vessel spasm

    3 days

  • Diagnostic accuracy of MDCTA

    3 days

  • Characteristics of spasm-related coronary artery segment

    3 days

Study Arms (2)

Spasm positive

EXPERIMENTAL

Ergonovine-induced coronary spasm provocation test positive: defined as transient, total, or sub-total occlusion (\>90% stenosis) of a coronary artery with symptoms of myocardial ischemia (angina pain and ischemic ECG change).

Diagnostic Test: Spasm positive

Spasm negative

PLACEBO COMPARATOR

Suspected vasospastic angina subjects with negative ergonovine provocation test are considered as reference modality.

Diagnostic Test: Spasm negative

Interventions

Spasm positiveDIAGNOSTIC_TEST

Investigators define the positive criteria for VSA on MDCTA as follows: 1. Significant stenosis (≥ 50%) with negative remodeling but no definite evidence of plaques, which completely dilated on IV nitrate CT, or 2. Diffuse small diameter (\< 2mm) of a major coronary artery with beaded appearance which completely dilated on IV nitrate CT.

Spasm positive
Spasm negativeDIAGNOSTIC_TEST

Suspected vasospastic angina subjects with negative MDCTA-derived VSA are considered as reference modality.

Spasm negative

Eligibility Criteria

Age20 Years - 80 Years
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Subject is onset of angina-like attack at rest, during effort, or during rest and effort.
  • Subject has chest pain between night and early morning.
  • Subject is scheduled to undergo MDCTA.
  • Subject is an acceptable candidate for CAG with an EG provocation test.
  • Cardiac condition: BP\>90/60mmHg, ECG: sinus rhythm with regular, left ventricular ejection fraction\>55%, and resting heart rate\<100 beats/min.
  • Subject will be provided written informed consent.
  • Subject is willing to comply with study follow-up requirement.

You may not qualify if:

  • Subject has clinical evidence of acute coronary syndrome.
  • Subject has evidence of significant narrowing (\>50% stenosis by CAG).
  • Subject has clinical evidence of cardiomyopathy or valvular heart disease.
  • Subject is hemodynamically unstable.
  • Subject has a history of PCI and CABG.
  • Subject is pregnant and/or breastfeeding or intends to become pregnant during the duration of the study.
  • Subject has known allergy to contrast medium.
  • Subject has renal insufficiency (serum creatine \>2.5 mg/dl).

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Dong-A University Hospital

Busan, 602-715, South Korea

RECRUITING

Related Publications (2)

  • Kang EJ, Kim MH, De Jin C, Seo J, Kim DW, Yoon SK, Park TH, Lee KN, Choi SI, Yoon YE. Noninvasive detection of coronary vasospastic angina using a double-acquisition coronary CT angiography protocol in the presence and absence of an intravenous nitrate: a pilot study. Eur Radiol. 2017 Mar;27(3):1136-1147. doi: 10.1007/s00330-016-4476-2. Epub 2016 Jul 6.

    PMID: 27380904BACKGROUND
  • Jin C, Kim MH, Kang EJ, Cho YR, Park TH, Lee KN, Serebruany V. Assessing Vessel Tone during Coronary Artery Spasm by Dual-Acquisition Multidetector Computed Tomography Angiography. Cardiology. 2018;139(1):25-32. doi: 10.1159/000478926. Epub 2017 Nov 23.

    PMID: 29166637BACKGROUND

MeSH Terms

Conditions

SpasmCoronary Vasospasm

Condition Hierarchy (Ancestors)

Neuromuscular ManifestationsNeurologic ManifestationsNervous System DiseasesSigns and SymptomsPathological Conditions, Signs and SymptomsCoronary DiseaseMyocardial IschemiaHeart DiseasesCardiovascular DiseasesVascular Diseases

Study Officials

  • Moo Hyun Kim, MD

    Dong-A University Hospital

    PRINCIPAL INVESTIGATOR

Central Study Contacts

Study Design

Study Type
interventional
Phase
not applicable
Allocation
NON RANDOMIZED
Masking
NONE
Purpose
DIAGNOSTIC
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Professor, Dept. of Cardiology, Dong-A University Hospital

Study Record Dates

First Submitted

May 29, 2018

First Posted

June 27, 2018

Study Start

March 1, 2018

Primary Completion

May 31, 2021

Study Completion

July 1, 2021

Last Updated

August 4, 2020

Record last verified: 2020-08

Locations